Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning

Brachytherapy

Volumn 13, Issue 1, 2014, Pages 75-79

  Batchelar, Deidre ^a   Gaztañaga, Miren ^a   Schmid, Matt ^a   Araujo, Cynthia ^a   Bachand, François ^a   Crook, Juanita ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

High dose rate brachytherapy; Prostatic neoplasms; Ultrasound based planning; Varian Vitesse

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; BRACHYTHERAPY IMPLANT; CLINICAL ARTICLE; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MEASUREMENT ACCURACY; NEEDLE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RADIATION HAZARD; RADIOTHERAPY PLANNING SYSTEM; RADIOTHERAPY SOFTWARE; RISK ASSESSMENT; STANDARD; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY; VALIDATION STUDY; COMPUTER ASSISTED RADIOTHERAPY; ECHOGRAPHY; MEGAVOLTAGE RADIOTHERAPY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; RADIOGRAPHY; REPRODUCIBILITY;

BRACHYTHERAPY; CONE-BEAM COMPUTED TOMOGRAPHY; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, HIGH-ENERGY; REPRODUCIBILITY OF RESULTS;

EID: 84892494026     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2013.08.004     Document Type: Article

References (22)

1. Kupelian P.A., Langen K.M., Willoughby T.R., et al. Image-guided radiotherapy for localized prostate cancer: Treating a moving target. Semin Radiat Oncol 2008, 18:58-66.
2. Poli M.E., Parker W., Patrocinio H., et al. An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations. Int J Radiat Oncol Biol Phys 2007, 67:1430-1437.
3. Beltran C., Herman M.G., Davis B.J. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. Int J Radiat Oncol Biol Phys 2008, 70:289-295.
4. Fuller D.B., Koziol J.A., Feng A.C. Prostate brachytherapy seed migration and dosimetry: Analysis of stranded sources and other potential predictive factors. Brachytherapy 2004, 3:10-19.
5. Nag S., Vivekanandam S., Martinez-Monge R. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997, 39:667-670.
6. Older R.A., Synder B., Krupski T.L., et al. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. J Urol 2001, 165:1590-1592.
7. Pinkawa M., Asadpour B., Gagel B., et al. Evaluation of source displacement and dose-volume changes after permanent prostate brachytherapy with stranded seeds. Radiother Oncol 2007, 84:190-196.
8. Tiong A., Bydder S., Ebert M., et al. A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible. Int J Radiat Oncol Biol Phys 2010, 76:1066-1072.
9. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001, 166:876-881.
10. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:67-74.
11. Stock R.G., Stone N.N., Cesaretti J.A., et al. Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys 2006, 64:527-533.
12. Deutsch I., Zelefsky M.J., Zhang Z., et al. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. Brachytherapy 2010, 9:13-18.
13. Pieters B.R., de Back D.Z., Koning C.C., et al. Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: A systematic review. Radiother Oncol 2009, 93:168-173.
14. Bachand F., Martin A.G., Beaulieu L., et al. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: Biopsy and PSA outcome. Int J Radiat Oncol Biol Phys 2009, 73:679-684.
15. Holly R., Morton G.C., Sankreacha R., et al. Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy. Brachytherapy 2011, 10:299-305.
16. Kim Y., Hsu I.C., Lessard E., et al. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys 2004, 59:1208-1216.
17. Kim Y., Hsu I.C., Pouliot J. Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys 2007, 8:2415.
18. Seppenwoolde Y., Kolkman-Deurloo I.K., Sipkema D., et al. HDR prostate monotherapy: Dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging. Radiother Oncol 2008, 86:114-119.
19. Yoshida K., Yamazaki H., Nose T., et al. Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. Brachytherapy 2010, 9:36-41.
20. Schmid M., Crook J., Batchelar D., et al. A phantom study to assess accuracy of needle identification in real-time planning of ultrasound-guided high-dose-rate prostate implants. Brachytherapy 2013, 12:56-64.
21. Siebert F.A., Hirt M., Niehoff P., et al. Imaging of implant needles for real-time HDR-brachytherapy prostate treatment using biplane ultrasound transducers. Med Phys 2009, 36:3406-3412.
22. Pantelis E., Papagiannis P., Anagnostopoulos G., et al. Evaluation of a TG-43 compliant analytical dosimetry model in clinical 192Ir HDR brachytherapy treatment planning and assessment of the significance of source position and catheter reconstruction uncertainties. Phys Med Biol 2004, 49:55-67.